Literature DB >> 35597875

Changes in Gastric Inhibitory Polypeptide (GIP) After Roux-en-Y Gastric Bypass in Obese Patients: a Meta-analysis.

Zhiguang Gao1, Jingge Yang2, Yuzhi Liang3, Sen Yang4, Tao Zhang5, Zuyuan Gong5, Min Li5.   

Abstract

This meta-analysis aimed to evaluate changes in GIP after RYGB in obese patients. We searched PubMed, EMBASE, and CENTRAL for relevant studies from database inception through July 2021. Articles were eligible for inclusion if they reported pre-operative and post-operative fasting GIP levels. We found fasting GIP levels had a decreasing tendency. The decrease in fasting glucose and postprandial GIP levels was also observed. Subgroup analysis indicated diabetic subjects tended to have a more obvious fasting GIP reduction compared to non-diabetic individuals. Meta-regression showed that the amount of weight loss (% total body weight), gastric pouch volume, alimentary limb length, and biliopancreatic limb length were not related to fasting GIP decrease. Fasting GIP levels decreased significantly after RYGB in obese people, especially in diabetic patients.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  GIP; Gastric inhibitory polypeptide; Meta-analysis; Roux-en-Y gastric bypass

Mesh：

Substances：

Year:  2022        PMID： 35597875     DOI： 10.1007/s11695-022-05959-4

Source DB:  PubMed          Journal:  Obes Surg        ISSN： 0960-8923            Impact factor:   3.479


  12 in total

1.  Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial.

Authors:  Geltrude Mingrone; Simona Panunzi; Andrea De Gaetano; Caterina Guidone; Amerigo Iaconelli; Esmeralda Capristo; Ghassan Chamseddine; Stefan R Bornstein; Francesco Rubino
Journal:  Lancet       Date:  2021-01-23       Impact factor: 79.321

2.  Prospective evaluation of insulin and incretin dynamics in obese adults with and without diabetes for 2 years after Roux-en-Y gastric bypass.

Authors:  Jonathan Q Purnell; Geoffrey S Johnson; Abdus S Wahed; Chiara Dalla Man; Francesca Piccinini; Claudio Cobelli; Ronald L Prigeon; Bret H Goodpaster; David E Kelley; Myrlene A Staten; Karen E Foster-Schubert; David E Cummings; David R Flum; Anita P Courcoulas; Peter J Havel; Bruce M Wolfe
Journal:  Diabetologia       Date:  2018-02-10       Impact factor: 10.122

3.  Comparative Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Glucose Homeostasis and Incretin Hormones in Obese Type 2 Diabetic Patients: A One-Year Prospective Study.

Authors:  G Nosso; E Griffo; M Cotugno; G Saldalamacchia; R Lupoli; G Pacini; G Riccardi; L Angrisani; B Capaldo
Journal:  Horm Metab Res       Date:  2016-01-20       Impact factor: 2.936

4.  Comparison of Short- and Mid-term Efficacy and the Mechanisms of Gastric Bypass Surgeries on Managing Obese and Nonobese Type 2 Diabetes Mellitus: A Prospective Study.

Authors:  Xiaojuan Zhang; Zhong Cheng; Zhu Xiao; Xiao Du; Juan Du; Yang Li; Yang Long; Hongling Yu; Xiangxun Zhang; Haoming Tian
Journal:  Arch Med Res       Date:  2015-06-15       Impact factor: 2.235

5.  Gastric Bypass Reduces Symptoms and Hormonal Responses in Hypoglycemia.

Authors:  Niclas Abrahamsson; Joey Lau Börjesson; Magnus Sundbom; Urban Wiklund; F Anders Karlsson; Jan W Eriksson
Journal:  Diabetes       Date:  2016-06-16       Impact factor: 9.461

6.  Changes of blood glucose and gastrointestinal hormones 4 months after Roux-en-Y gastric bypass surgery in Chinese obese type 2 diabetes patients with lower body mass index.

Authors:  Qianlin Wu; Zhu Xiao; Zhong Cheng; Haoming Tian
Journal:  J Diabetes Investig       Date:  2012-11-20       Impact factor: 4.232

Review 7.  Potential Hormone Mechanisms of Bariatric Surgery.

Authors:  Georgios K Dimitriadis; Manpal S Randeva; Alexander D Miras
Journal:  Curr Obes Rep       Date:  2017-09

8.  Comparing the 5-Year Diabetes Outcomes of Sleeve Gastrectomy and Gastric Bypass: The National Patient-Centered Clinical Research Network (PCORNet) Bariatric Study.

Authors:  Kathleen M McTigue; Robert Wellman; Elizabeth Nauman; Jane Anau; R Yates Coley; Alberto Odor; Julie Tice; Karen J Coleman; Anita Courcoulas; Roy E Pardee; Sengwee Toh; Cheri D Janning; Neely Williams; Andrea Cook; Jessica L Sturtevant; Casie Horgan; David Arterburn
Journal:  JAMA Surg       Date:  2020-05-20       Impact factor: 14.766

9.  Rapid changes in neuroendocrine regulation may contribute to reversal of type 2 diabetes after gastric bypass surgery.

Authors:  Petros Katsogiannos; Prasad G Kamble; Urban Wiklund; Magnus Sundbom; Daniel Espes; Ulf Hammar; F Anders Karlsson; Maria J Pereira; Jan W Eriksson
Journal:  Endocrine       Date:  2020-01-26       Impact factor: 3.633

10.  Proglucagon peptide secretion profiles in type 2 diabetes before and after bariatric surgery: 1-year prospective study.

Authors:  Kleopatra Alexiadou; Joyceline Cuenco; James Howard; Nicolai Jacob Wewer Albrechtsen; Ibiyemi Ilesanmi; Anna Kamocka; George Tharakan; Preeshila Behary; Paul R Bech; Ahmed R Ahmed; Sanjay Purkayastha; Robert Wheller; Matthieu Fleuret; Jens Juul Holst; Stephen R Bloom; Bernard Khoo; Tricia M-M Tan
Journal:  BMJ Open Diabetes Res Care       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.